Management of thrombosis in cancer : primary prevention and secondary prophylaxisLEE, Agnes Y. Y.British journal of haematology. 2005, Vol 128, Num 3, pp 291-302, issn 0007-1048, 12 p.Article

VTE in Patients with Cancer-Diagnosis, Prevention, and TreatmentLEE, Agnes.Thrombosis research. 2008, Vol 123, issn 0049-3848, S50-S54, SUP1Conference Paper

Treatment of venous thromboembolism in cancer patientsLEE, Agnes Y. Y.Thrombosis research. 2001, Vol 102, Num 6, pp 195-208, issn 0049-3848Article

Epidemiology and management of venous thromboembolism in patients with cancerLEE, Agnes Y. Y.Thrombosis research. 2003, Vol 110, Num 4, pp 167-172, issn 0049-3848, 6 p.Article

Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementLEE, Agnes; AGNELLI, Giancarlo; VAN DER MEER, Jan et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 1, pp 74-78, issn 0009-7322Article

Predicting Deep Venous Thrombosis in Pregnancy: Out in LEFt Field?CHAN, Wee-Shian; LEE, Agnes; SPENCER, Frederick A et al.Annals of internal medicine. 2009, Vol 151, Num 2, pp 85-92, issn 0003-4819, 8 p.Article

A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancyCHAN, Wee-Shian; CHUNILAL, Sanjeev; LEE, Agnes et al.Annals of internal medicine. 2007, Vol 147, Num 3, pp 165-170, issn 0003-4819, 6 p.Article

Rating dysthymia: an assessment of the construct and content validity of the Cornell Dysthymia Rating ScalesHELLERSTEIN, David J; BATCHELDER, Sarai T; LEE, Agnes et al.Journal of affective disorders. 2002, Vol 71, Num 1-3, pp 85-96, issn 0165-0327Article

A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancyPALARETI, Gualtiero; LEGNANI, Cristina; LEE, Agnes et al.Thrombosis and haemostasis. 2000, Vol 84, Num 5, pp 805-810, issn 0340-6245Article

A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis : D-dimer testing compared with repeated ultrasonographyKEARON, Clive; GINSBERG, Jeffrey S; DOUKETIS, James et al.Annals of internal medicine. 2005, Vol 142, Num 7, pp 490-496, issn 0003-4819, 7 p.Article

How we diagnose and treat deep vein thrombosisHIRSH, Jack; LEE, Agnes Y. Y.Blood. 2002, Vol 99, Num 9, pp 3102-3110, issn 0006-4971Article

Malignancy and venous thrombosis in the critical care patientWU, Cynthia; LEE, Agnes Y.Critical care medicine. 2010, Vol 38, Num 2, issn 0090-3493, S64-S70, SUPArticle

Prevention of Deep Vein Thrombosis in Cancer PatientsLEE, Agnes Y. Y.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 7, pp 699-706, issn 0094-6176, 8 p.Article

Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patientsKOVACS, Michael J; LEVINE, Mark N; KEENEY, Michael et al.Thrombosis and haemostasis. 2005, Vol 93, Num 6, pp 1185-1188, issn 0340-6245, 4 p.Article

The roles of anticoagulants in patients with cancerLEE, Agnes Y. Y.Thrombosis research. 2010, Vol 125, issn 0049-3848, S8-S11, SUP2Conference Paper

Treatment of venous thrombosis in the cancer patientLEVINE, Mark N; LEE, Agnes Y. Y.Acta haematologica. 2001, Vol 106, Num 1-2, pp 81-87, issn 0001-5792Article

Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With CancerLEE, Agnes Y. Y.Journal of clinical oncology. 2009, Vol 27, Num 29, pp 4895-4901, issn 0732-183X, 7 p.Article

Cancer and thromboembolic disease: pathogenic mechanismsLEE, Agnes Y.Cancer treatment reviews. 2002, Vol 28, Num 3, pp 137-140, issn 0305-7372, 4 p.Conference Paper

Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by α₂-antiplasminLEE, Agnes Y. Y; FREDENBURGH, James C; STEWART, Ronald J et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 502-508, issn 0340-6245Article

DNA analysis for the Dombrock polymorphismRIOS, Maria; HUE-ROYE, Kim; LEE, Agnes H et al.Transfusion (Philadelphia, PA). 2001, Vol 41, Num 9, pp 1143-1146, issn 0041-1132Article

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancerLEE, Agnes Y. Y; LEVINE, Mark N; BUTLER, Gregory et al.Journal of clinical oncology. 2006, Vol 24, Num 9, pp 1404-1408, issn 0732-183X, 5 p.Article

Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patientsCARRIER, Marc; LEE, Agnes Y. Y; BATES, Shannon M et al.Thrombosis research. 2008, Vol 123, Num 1, pp 177-183, issn 0049-3848, 7 p.Article

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous ThromboembolismLOUZADA, Martha L; CARRIER, Marc; WELLS, Philip S et al.Circulation (New York, N.Y.). 2012, Vol 126, Num 4, pp 448-454, issn 0009-7322, 7 p.Article

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerLEE, Agnes Y. Y; LEVINE, Mark N; KOVACS, Michael J et al.The New England journal of medicine. 2003, Vol 349, Num 2, pp 146-153, issn 0028-4793, 8 p.Article

What is the role for antithrombotics in cancer care? Interactive session with panel discussionKAKKAR, Ajay K; LEVINE, Mark N; PRANDONI, Paolo et al.Cancer treatment reviews. 2002, Vol 28, Num 3, pp 157-159, issn 0305-7372, 3 p.Conference Paper